Clinical Trial

Monitoring of Patient Physiological Parameters in Real Life Using OXYFLEX® Biosensors Versus Standard Monitoring

Study acronym: OXYVIVO
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to use the OXYFLEX® device in real care conditions during the hospital management of a population of patients from various hospital services. These services include patients from the severe trauma pathway, intensive care, the polyvalent intensive care unit, and the operating room. The objective is to assess the reliability of the data collected by the OXYFLEX® biosensor compared to those obtained from standard monitoring used in these different services and conditions.
Protocol Amendment History 4 changes
notable Primary completion pushed: 2026-12 -> 2027-01 2026-07-08
minor Completion pushed: 2026-12 -> 2027-01 2026-07-08
notable Primary completion pushed: 2026-06 -> 2026-12 2026-06-17
minor Completion moved earlier: 2027-01 -> 2026-12 2026-06-17
Trial Details
NCT Number NCT07037784
Lead Sponsor Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Conditions Physiological Parameters
Enrollment 102 participants
Start Date 2026-07
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-07